Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
Clinical trial NCT03095066 · COMPLETED
Trial details
- NCT number
- NCT03095066
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2022-08-22
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.